Related Experiment Videos
Insights
Newborn infants experiencing drug withdrawal should first receive supportive care. Pharmacologic treatment is recommended only when necessary, guided by objective assessments, with specific drugs targeting withdrawal symptoms.
Area of Science:
- Neonatal Medicine
- Pediatric Pharmacology
- Clinical Pediatrics
Background:
- Neonatal drug withdrawal is a significant clinical concern.
- Pharmacologic interventions are sometimes necessary for managing withdrawal symptoms in newborns.
- Excipients in medications can pose risks to infants.
Purpose of the Study:
- To provide guidance on the management of drug withdrawal in newborn infants.
- To emphasize the role of supportive care as the primary treatment modality.
- To outline criteria for initiating and discontinuing pharmacologic therapy.
Main Methods:
- Review of current recommendations and clinical practices.
- Emphasis on objective assessment tools like abstinence scoring sheets.
- Consideration of specific pharmacologic agents for targeted symptom relief.
Main Results:
- Supportive care is the recommended first-line therapy.
- Objective scoring systems should guide pharmacologic treatment decisions.
- Specific medications (e.g., phenobarbital, opiates) are indicated for corresponding withdrawal types.
- Potential adverse effects from drug excipients require careful attention.
Conclusions:
- A balanced approach combining supportive care and judicious pharmacologic treatment is crucial.
- Physicians should utilize objective measures to personalize treatment plans.
- Awareness of medication excipients is vital for infant safety in managing neonatal drug withdrawal.
Abstract:
The Committee on Drugs of the American Academy of Pediatrics recommends that thoughtful consideration be given to the need for administration of pharmacologic agents to newborn infants who have symptoms of drug withdrawal. Supportive care should be the first line of therapy, and objective methods such as an abstinence scoring sheet should be used to determine the need for instituting and then discontinuing pharmacologic treatment. When appropriate, specific drug therapy should be used for treatment of withdrawal symptoms (ie, phenobarbital for phenobarbital withdrawal and opiate for opiate withdrawal). Attention should be given to potential adverse effects in the infant resulting from excipients present in many of the drugs (Table 2). The information provided herein should serve as a guide for the physician in providing supportive care and pharmacologic treatment of the infant suffering from drug withdrawal.